Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies

JG Foster, MD Blunt, E Carter, SG Ward - Pharmacological reviews, 2012 - ASPET
The phosphoinositide 3-kinase/mammalian target of rapamycin/protein kinase B
(PI3K/mTOR/Akt) signaling pathway is central to a plethora of cellular mechanisms in a wide …
被引用次数：153 相关文章

Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies

JG Foster, MD Blunt, E Carter… - Pharmacological …, 2012 - pubmed.ncbi.nlm.nih.gov
The phosphoinositide 3-kinase/mammalian target of rapamycin/protein kinase B
(PI3K/mTOR/Akt) signaling pathway is central to a plethora of cellular mechanisms in a wide …

Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies

JG Foster, MD Blunt, E Carter… - Pharmacological …, 2012 - eprints.soton.ac.uk
The phosphoinositide 3-kinase/mammalian target of rapamycin/protein kinase B
(PI3K/mTOR/Akt) signaling pathway is central to a plethora of cellular mechanisms in a wide …

Inhibition of PI3K signaling Spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies

JG Foster, MD Blunt, E Carter, SG Ward - Pharmacological Reviews, 2012 - hero.epa.gov
The phosphoinositide 3-kinase/mammalian target of rapamycin/protein kinase B
(PI3K/mTOR/Akt) signaling pathway is central to a plethora of cellular mechanisms in a wide …

Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies.

JG Foster, MD Blunt, E Carter, SG Ward - Pharmacological Reviews, 2012 - europepmc.org
The phosphoinositide 3-kinase/mammalian target of rapamycin/protein kinase B
(PI3K/mTOR/Akt) signaling pathway is central to a plethora of cellular mechanisms in a wide …

Inhibition of PI3K signaling Spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies

JG Foster, MD Blunt, E Carter… - Pharmacological …, 2012 - researchportal.bath.ac.uk
The phosphoinositide 3-kinase/mammalian target of rapamycin/protein kinase B
(PI3K/mTOR/Akt) signaling pathway is central to a plethora of cellular mechanisms in a wide …

[引用][C] Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies

JG Foster, MD Blunt, E Carter, SG Ward - Pharmacological Reviews, 2012 - cir.nii.ac.jp
Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune
Diseases and Hematological Malignancies | CiNii Research CiNii 国立情報学研究所 学術 …